EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED

Accounts Submitted 27 May 2025

Confirmation Statement Submitted 29 Sept 2025

Net assets £1.21M £1.00K 2024 year on year

Total assets £1.28M £39.00K 2024 year on year

Total Liabilities £69.00K £38.00K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Shewalton Road Irvine Ayrshire KA11 5AP

Credit Report

Discover EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1.21M

Decreased by £1.00k (-0%)

Total Liabilities

£69.00k

Decreased by £38.00k (-36%)

Turnover

N/A

Employees

N/A

Debt Ratio

Decreased by 3 (-38%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 22 resigned

Show resigned officers

						Status
Ciara Martha Lynch	Director	Irish	England	57	2 Mar 2020	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	31 Jan 2001	Active
The Wellcome Foundation Limited	Corporate-director	United Kingdom	Unknown	—	17 Feb 2020	Active
Victoria Anne Whyte	Secretary	British	Unknown	—	31 Jan 2001	Active

Shareholders

Shareholders (2)


Glaxo Group Ltd	95.1%	250,000	Ordinary	29 Sept 2015
Glaxo Group Ltd	4.9%	13,000	Preference	29 Sept 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Current Company

CLARGES PHARMACEUTICALS TRUSTEES LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent, appoint/remove directors

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
29 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-29 with no updates	View(3 pages)
4 Jul 2025	Officers	Change to director Mrs Ciara Martha Lynch on 2025-06-27	View(2 pages)
27 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(14 pages)
27 May 2025	Accounts	Annual accounts filed	View(344 pages)
27 May 2025	Other	Notice of agreement to exemption from audit of accounts for period ending 31/12/24	View(1 page)